Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric McDade

Showing results (121-130 of 194) with videos related to

Pageof 20
Sort By:
Neurology|August 7, 2015
Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer diseaseFen Wang, Brian A Gordon, Davis C Ryman, et al.
Clinical Investigation|November 10, 2012
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer NetworkJohn C Morris, Paul S Aisen, Randall J Bateman, et al.
Nature Medicine|February 19, 2026
Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocksKellen K Petersen, Marta Milà-Alomà, Yan Li, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN)Andrew J Aschenbrenner, Bryan D James, Eric McDade, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 23, 2020
Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypesJorge J Llibre-Guerra, Yan Li, Ricardo F Allegri, et al.
Brain : a Journal of Neurology|March 10, 2018
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageingJasmeer P Chhatwal, Aaron P Schultz, Keith A Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 25, 2025
Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's diseaseJulie K Wisch, Nicole S McKay, Matthew Zammit, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Pageof 20

Showing results (121-130 of 194) with videos related to

Sort By:
Pageof 20
Neurology|August 7, 2015
Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer diseaseFen Wang, Brian A Gordon, Davis C Ryman, et al.
Clinical Investigation|November 10, 2012
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer NetworkJohn C Morris, Paul S Aisen, Randall J Bateman, et al.
Nature Medicine|February 19, 2026
Predicting onset of symptomatic Alzheimer's disease with plasma p-tau217 clocksKellen K Petersen, Marta Milà-Alomà, Yan Li, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN)Andrew J Aschenbrenner, Bryan D James, Eric McDade, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 23, 2020
Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypesJorge J Llibre-Guerra, Yan Li, Ricardo F Allegri, et al.
Brain : a Journal of Neurology|March 10, 2018
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageingJasmeer P Chhatwal, Aaron P Schultz, Keith A Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 25, 2025
Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's diseaseJulie K Wisch, Nicole S McKay, Matthew Zammit, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Pageof 20